CSIMarket
 
Anzu Special Acquisition Corp I  (NASDAQ: COCH)
Other Ticker:  
 
 
Price: $1.5400 $-0.02 -1.282%
Day's High: $1.63 Week Perf: -7.78 %
Day's Low: $ 1.53 30 Day Perf: 6.94 %
Volume (M): 21 52 Wk High: $ 11.46
Volume (M$): $ 32 52 Wk Avg: $2.93
Open: $1.56 52 Wk Low: $1.16



 Market Capitalization (Millions $) 30
 Shares Outstanding (Millions) 20
 Employees 7
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -16
 Cash Flow (TTM) (Millions $) 17
 Capital Exp. (TTM) (Millions $) 2

Anzu Special Acquisition Corp I
Envoy Medical Inc. is a medical technology company specializing in innovative solutions for hearing loss. The company's flagship product is the Esteem' Hearing Implant, a fully implantable hearing device that offers a permanent solution to hearing loss. The Esteem device uses the natural structures of the ear to deliver clear and natural sound without the need for external hardware, such as hearing aids or batteries. Envoy Medical Inc. is dedicated to improving the lives of individuals with hearing loss by providing them with long-lasting and effective solutions for better hearing.


   Company Address: 4875 White Bear Parkway White Bear Lake 55110 MN
   Company Phone Number: 900-3277   Stock Exchange / Ticker: NASDAQ COCH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
PEP        0.47% 
• View Complete Report
   



Announcement

Envoy Medical Advances Hearing Health with New Patent Protections and Clinical Study Initiation

Published Sun, Dec 29 2024 6:28 PM UTC

In a significant leap toward redefining hearing loss treatment, Envoy Medical, Inc. has recently announced the granting of four new patents and the initiation of a pivotal clinical study for its innovative hearing solutions. Based in White Bear Lake, Minnesota, Envoy Medical (NASDAQ: COCH) is at the forefront of developing fully implanted cochlear implant systems that promis...

Announcement

Revolutionizing Hearing The Promise of Fully Implanted Cochlear Technology

Published Tue, Nov 12 2024 2:25 PM UTC

In a notable advancement in the field of auditory health, Envoy Medical has ushered in a breakthrough with its Fully Implanted Acclaim Cochlear Implant, recently spotlighted in a peer-reviewed study published in the esteemed journal Otology & Neurotology . This innovative device stands to reshape the lives of individuals with severe hearing loss by offering a seamless and d...

Announcement

Envoy Medical Secures Pivotal European Patent for Groundbreaking Modular Cochlear Implant System, Enhancing the Futur...

Published Fri, Nov 8 2024 2:25 PM UTC

Envoy Medical Expands Intellectual Property Portfolio with New European Patent for Advanced Cochlear Implant System WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 Envoy Medical, Inc. (NASDAQ: COCH), a pioneer in the development of fully implanted hearing systems, has announced a significant milestone in its quest to enhance auditory experiences for individuals with hearing lo...

Announcement

Revamping Hearing Loss Treatment Envoy Medicals Groundbreaking Cochlear Implant Receives FDA Green Light for P...

Published Fri, Nov 1 2024 12:00 PM UTC

In a significant advancement in the field of auditory health, Envoy Medical has received FDA approval to initiate a pivotal clinical study for its revolutionary Acclaim fully implanted cochlear device. This announcement opens a new chapter in the treatment of hearing loss, aiming to provide patients with a more viable solution that is not only effective but also less obtrusi...

Announcement

Envoy Medical Celebrating a Milestone While Strengthening Its Position in the Hearing Health Market

Published Tue, Oct 1 2024 12:00 PM UTC

As Envoy Medical marks its first anniversary of trading under the ticker COCH on the Nasdaq Capital Market, the company stands at a pivotal threshold for growth and development in the hearing health industry. In addition to its successful de-SPAC merger and the completion of its sixty-day washout period, the recent developments signal a promising future for this innovative c...







Anzu Special Acquisition I's Segments





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com